Neurotherapeutics, 2015 · DOI: 10.1007/s13311-014-0308-8 · Published: November 5, 2014
Localized protein synthesis allows cells to react quickly to environmental changes. In nerve cells, this is vital for forming connections during development. Mature nerve axons, once thought inactive, can also synthesize proteins locally upon injury or in neurodegenerative diseases. These locally made proteins can either help repair damage or contribute to disease. Targeting this protein synthesis could be a way to treat conditions like spinal cord injury or Alzheimer’s disease. Scientists are developing tools to specifically target protein synthesis in axons. While many questions remain, manipulating axonal protein synthesis is a promising approach for treating neurological disorders.
Targeting axonal protein synthesis offers a novel avenue for developing therapies for conditions like spinal cord injury, Alzheimer's disease, ALS and SMA.
Investigating the axonal translatome can provide invaluable insight into pathological changes induced by neurodegenerative stimuli, leading to a better understanding of disease mechanisms.
The review highlights the need for developing tools that selectively modify the axonal transcriptome or translatome to avoid unwanted side effects in other neuronal compartments.